H.C. Wainwright analyst Joseph Pantginis reiterated a Buy rating on Viking Therapeutics (VKTX – Research Report) today and set a price target ...

Equities research analysts at HC Wainwright issued their Q1 2025 earnings per share (EPS) estimates for Arvinas in a report issued on Wednesday, February 12th. HC Wainwright analyst A. Fein forecasts ...

In a report released today, Joseph Pantginis from H.C. Wainwright maintained a Buy rating on Lexicon Pharmaceuticals (LXRX – Research Report), ...

Stock analysts at StockNews.com assumed coverage on shares of DURECT (NASDAQ:DRRX – Get Free Report) in a research report issued on Saturday. The brokerage set a “sell” rating on the specialty ...

Fate Therapeutics, Inc. (NASDAQ: FATE), a clinical-stage biopharmaceutical company dedicated to bringing a first-in-class ...

Carl Spana; President, Chief Executive Officer, Director; Palatin Technologies Inc Stephen Wills; Chief Financial Officer, Chief Operating Officer, Executive Vice President, Treasurer, Secretary; ...

Bonny Simi, President of Operations at Joby Aviation , Inc. (NYSE:JOBY), recently executed a stock transaction that saw the sale of 8,628 shares of common stock. The shares were sold on February 13, ...

CFO Beth Jantzen reported total revenues of $1.2 million for Q1 2025, a year-over-year increase driven by higher product revenue from DNA Tagging and increased isotopic testing services. Operating ...

Shares of Coinbase Global Inc (NASDAQ: COIN) plunged despite upbeat Q4 revenues. Analysts maintain Buy/Nuetral ratings with price targets as high as $475.

TORONTO, Feb. 14, 2025 (GLOBE NEWSWIRE) -- Edesa Biotech, Inc. (Nasdaq:EDSA), a clinical-stage biopharmaceutical company ...